Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Annabelle Santos Volgman   and   Tisha Suboc.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            2.059
         
        
        
     
 
    
        
        - 
            Lessons Learned from Coronavirus Disease 2019 Sex Disparities. J Womens Health (Larchmt). 2021 04; 30(4):453-454.
            
            
                Score: 0.728
             
- 
            End-Of-Life Care for Patients With End-Stage Heart Failure, Comparisons of International Guidelines. Am J Hosp Palliat Care. 2024 Jan; 41(1):87-98.
            
            
                Score: 0.207
             
- 
            Editorial commentary: COVID-19 as a cardiovascular disease risk factor. Trends Cardiovasc Med. 2022 11; 32(8):476-478.
            
            
                Score: 0.199
             
- 
            Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients. Am Heart J Plus. 2022 Feb; 14:100134.
            
            
                Score: 0.196
             
- 
            The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol. 2021 Nov-Dec; 55:107374.
            
            
                Score: 0.186
             
- 
            Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19. Am Heart J Plus. 2021 Apr; 4:100022.
            
            
                Score: 0.185
             
- 
            Sex Differences in Takotsubo Syndrome: A Narrative Review. J Womens Health (Larchmt). 2020 08; 29(8):1122-1130.
            
            
                Score: 0.164
             
- 
            Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease. Am Heart J Plus. 2022 Aug; 20:100189.
            
            
                Score: 0.050
             
- 
            Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc. 2022 09 20; 11(18):e025198.
            
            
                Score: 0.050
             
- 
            Prognostic value of H2FPEF score in COVID-19. Am Heart J Plus. 2022 Jan; 13:100111.
            
            
                Score: 0.048
             
- 
            Cardiovascular findings on chest computed tomography associated with COVID-19 adverse clinical outcomes. Am Heart J Plus. 2021 Nov; 11:100052.
            
            
                Score: 0.047